Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

about

Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.

P2860

Q48178320-8CF632CA-E227-40B6-85DB-2D507E1A667F

P2860

Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

Item

http://www.wikidata.org/entity/Q40077021

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

@en

type

Item

label

Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

@en

prefLabel

Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

@en

P1476

Methodologic Issues When Estimating Risks in Pharmacoepidemiology

@en

P2093

Jessie K Edwards

http://www.w3.org/2001/XMLSchema#string

Laura L Hester

http://www.w3.org/2001/XMLSchema#string

Mugdha Gokhale

http://www.w3.org/2001/XMLSchema#string

P2860

The parametric g-formula for time-to-event data: intuition and a worked example

Occupational radon exposure and lung cancer mortality: estimating intervention effects using the parametric g-formula

Nonparametric Estimation from Incomplete Observations

Marginal structural models and causal inference in epidemiology

Improved estimates of cancer-specific survival rates from population-based data

Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Understanding competing risks: a simulation point of view

Competing risk regression models for epidemiologic data.

Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death

P2888

s40471-016-0089-1

P304

285-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40471-016-0089-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Catherine R Lesko

P577

2016-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28824834

http://www.w3.org/2001/XMLSchema#string

P932

5557056

http://www.w3.org/2001/XMLSchema#string

Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

about

P2860

P2860

Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932